Journal
HUMAN MUTATION
Volume 29, Issue 11, Pages 1265-1272Publisher
WILEY-LISS
DOI: 10.1002/humu.20897
Keywords
likelihood models; unclassified variants; integrated model; classification
Categories
Funding
- National Institutes of Health (NIH) [CA116167, CA96536]
- Lake Champlain Cancer Research Organization
Ask authors/readers for more resources
Genetic testing often results in the finding of a variant whose clinical significance is unknown. A number of different approaches have been employed in the attempt to classify such variants. For some variants, case-control, segregation, family history, or other statistical studies can provide strong evidence of direct association with cancer risk. For most variants, other evidence is available that relates to properties of the protein or gene sequence. In this work we propose a Bayesian method for assessing the likelihood that a variant is pathogenic. We discuss the assessment of prior probability, and how to combine the various sources of data into a statistically valid integrated assessment with a posterior probability of pathogenicity. In particular, we propose the use of a two-component mixture model to integrate these various sources of data and to estimate the parameters related to sensitivity and specificity of specific kinds of evidence. Further, we discuss some of the issues involved in this process and the assumptions that underpin many of the methods used in the evaluation process. Hum Mutat 29(11), 1265-1272, 2008. (C) 2008 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available